Treatment of cancer with peptides
US5736517A · kind A · utility
7Cited by
10References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 8, 1993 |
| Grant date | Apr 7, 1998 |
| Priority date | — |
| Expiry date | Jun 8, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/31
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating cancer in a human patient, the method involving administering to the patient a cancer cell inhibiting amount of an analog of a naturally occurring biologically active peptide or a fragment thereof, the peptide being one of mammalian gastrin-releasing peptide, neuromedin B, neuromedin C, amphibian bombesin, or litorin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.